BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21107015)

  • 1. Nanoparticulate delivery systems for antiviral drugs.
    Lembo D; Cavalli R
    Antivir Chem Chemother; 2010; 21(2):53-70. PubMed ID: 21107015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has nanotechnology led to improved therapeutic outcomes?
    Bosselmann S; Williams RO
    Drug Dev Ind Pharm; 2012 Feb; 38(2):158-70. PubMed ID: 22191583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming in vivo barriers to targeted nanodelivery.
    Chrastina A; Massey KA; Schnitzer JE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):421-37. PubMed ID: 21538941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.
    Lembo D; Donalisio M; Civra A; Argenziano M; Cavalli R
    Expert Opin Drug Deliv; 2018 Jan; 15(1):93-114. PubMed ID: 28749739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosystem drug targeting: Facing up to complex realities.
    Ruenraroengsak P; Cook JM; Florence AT
    J Control Release; 2010 Feb; 141(3):265-76. PubMed ID: 19895862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered nanoparticles as precise drug delivery systems.
    Yih TC; Al-Fandi M
    J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
    Muller RH; Keck CM
    J Biotechnol; 2004 Sep; 113(1-3):151-70. PubMed ID: 15380654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of nanoparticulate systems for macrophage targeting.
    Chellat F; Merhi Y; Moreau A; Yahia L
    Biomaterials; 2005 Dec; 26(35):7260-75. PubMed ID: 16023200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine for respiratory diseases.
    Swai H; Semete B; Kalombo L; Chelule P; Kisich K; Sievers B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):255-63. PubMed ID: 20049795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges to macromolecular drug delivery.
    Juliano R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):41-3. PubMed ID: 17233596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control.
    Yang KC; Lin JC; Tsai HH; Hsu CY; Shih V; Hu CJ
    Drug Deliv Transl Res; 2021 Aug; 11(4):1420-1437. PubMed ID: 33748879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway delivery of peptides and proteins using nanoparticles.
    Dombu CY; Betbeder D
    Biomaterials; 2013 Jan; 34(2):516-25. PubMed ID: 23046753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled drug delivery systems: Part 3. In vitro/in vivo studies of the self-assembled nanoparticulates of cholesteryl acyl didanosine.
    Jin Y; Ai P; Xin R; Tian Y; Dong J; Chen D; Wang W
    Int J Pharm; 2009 Feb; 368(1-2):207-14. PubMed ID: 19007871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The past, present and future of antiviral drug discovery.
    Littler E
    IDrugs; 2004 Dec; 7(12):1104-12. PubMed ID: 15599804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.